Current reporting, research and professional developments across Clinical Psychology, curated for psychologists and behavioral-health professionals.
Learn how clinicians tackle mood and substance use disorders together, boost patient engagement, and expand evidence-based addiction medications for bipolar and alcohol use.
The FDA has approved a subcutaneous dose for initiation of lecanemab treatment in adults with Alzheimer’s disease, according to a press release from the administration.Previously, patients had to begin treatment with an…
Compass Pathways (NASDAQ:CMPS)'s COMP360 treatment model may face fewer regulatory hurdles as new Phase II analysis distinguishes the company’s psychological support approach from psychotherapy, ...
AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC)'s acquisition by Eli Lilly for up to $3.8 billion reinforces growing interest from large pharmaceutical companies in psychedelic-based therapies, according to ...
New research suggests GLP-1 medications like Ozempic and Wegovy may help ease symptoms of binge eating disorder and related eating behaviors.
Background Childhood maltreatment has been associated with poorer family functioning among college students with major depressive disorder (MDD). Nonetheless, the specific pathway through which childhood maltreatment…
Background/objectives Adolescent new psychoactive substance (NPS) users represent a high-risk population with complex psychological needs that remain insufficiently characterized, limiting the development of targeted…
The transition from late adolescence to emerging adulthood is a critical period of psychological and neurobiological change. Gaming disorder (GD), depression, and anxiety often co-occur, yet little is known about how…
Background Traumatic brain injuries (TBI) are frequently accompanied by neuropsychiatric disturbances. Failure to quickly assess and manage these disturbances results in neurobehavioral syndromes, with deleterious…
Background Cognitive impairments, particularly in the domain of memory, are core and enduring features of schizophrenia. Bone morphogenetic proteins (BMPs), members of the transforming growth factor-β superfamily, are…
Developing clear, adaptable, and engaging methodologies is critical for advancing the understanding and prevention of self-harm and suicide. This paper presents a review of the development, application and adaptation of…
Bipolar disorder (BD) is a chronic and recurrent psychiatric illness, and acute manic episodes are associated with marked functional impairment. Mood stabilizers and antipsychotics remain the mainstay of treatment…
Blood concentrations of amino acids have been associated with depression, although findings have been inconsistent. We investigated associations between serum amino acid concentrations and genetic liability to…
Background Prevalence of non-stereotypical Eating Disorders (EDs; e.g., characterized by normal weight, subjective binge eating) is much higher compared with stereotypical EDs (e.g., characterized by under- or…
Background In recent years, digital mental health interventions have become increasingly important due to the rising demand for psychotherapy and the shortage of resources. Digital inpatient-like psychotherapy (DIPT) is…
Oral THC/CBD combo rapidly eases severe dementia agitation in phase 2 trial, with sustained 12-week benefit and similar safety to placebo.
New review links lithium and Alzheimer disease treatment, fueling calls for biomarker-guided, low-dose clinical trials testing lithium’s multi-target disease-modifying potential.
Research published in The Orthopaedic Journal of Sports Medicine showed no significant effect of levels of preoperative anxiety on opioid usage in patients who were opioid naive undergoing primary arthroscopic rotator…
COMP360 psilocybin shows rapid, durable gains in treatment‑resistant depression, as psychedelics continue to grow.
A large laboratory study found that many commonly used sweeteners can directly change the growth of gut bacteria. Researchers identified more than 100 cases in which sweeteners behaved differently ...
Health experts are raising the alarm on kratom-derived 7-hydroxymitragynine, or 7-OH, products.At its annual House of Delegates meeting, the AMA expanded its policy regarding kratom products. The organization is now…
How shifting cannabis laws shape potency, access, and risk—revealing why anxiety, paranoia, and psychosis can surge when users cross regulatory borders.
People who pursue semi-retirement with a different employer experienced less cognitive decline compared with those who stayed with the same employer and those who pursued full retirement, according to a speaker.Gradually…
Learn how fast-acting oral zuranolone treats postpartum depression in days, with practical prescribing and breastfeeding guidance clinicians can use.
This acquisition marks Lilly’s first move into the psychedelic space as the pharma curates a diversified pipeline.
Warning letters from the Food and Drug Administration (FDA) have been issued to ketamine retailers Legit Ketamine Suppliers, Ketamine Troches and Ketamine Store for marketing unapproved and misbranded ...
The Delhi High Court has held that the University Grants Commission (UGC) and the Rehabilitation Council of India (RCI) cannot retrospectively apply the new regulatory framework governing Clinical ...
Anxiety and headaches tend to go hand-in-hand, so what's the connection between a panic attack and a migraine? Can a panic attack cause this type of pain?
By Skye Crawford Ben Ingraham wanted to be a doctor. He planned to attend medical school after serving as a U.S. Navy corpsman, but his time in the military was unexpectedly cut short. A traumatic ...
Anorexia Nervosa (AN) can be a complex condition to treat, often complicated by high chronicity, complexity and comorbidity. Treatments for AN with comorbidity and complexity are limited, with carers having to take a…
Send a personal recommendation to a friend.